Current treatment options for osteoporosis

Journal of Rheumatology

Volumn 23, Issue SUPPL. 45, 1996, Pages 11-14

  Adachi, Jonathan D ^a,b,c  

^a MCMASTER UNIVERSITY   (Canada)

^b ST JOSEPH S HOSPITAL   (Canada)

^c NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; CALCIUM; ESTROGEN; ETIDRONIC ACID; NORETHISTERONE; BISPHOSPHONIC ACID DERIVATIVE;

ADULT; AGED; BONE DENSITY; CONFERENCE PAPER; FEMALE; FRACTURE; HUMAN; MALE; OSTEOPOROSIS; PRIORITY JOURNAL; ESTROGEN THERAPY; EXERCISE; MIDDLE AGED; OSTEOLYSIS; PATIENT COMPLIANCE; POSTMENOPAUSE OSTEOPOROSIS; REVIEW;

ADULT; AGED; BONE RESORPTION; CALCITONIN; CALCIUM; DIPHOSPHONATES; ESTROGEN REPLACEMENT THERAPY; EXERCISE; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; PATIENT COMPLIANCE;

EID: 0029743525     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (14)

1. Consensus Development Conference: Diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 1993;96:646-50.
2. Chapman JA and the Osteoporosis Working Group: A randomized controlled dial to determine the effects of weight-bearing non aerobic exercise programme on the bone mineral density and morbidity on postmenopausal women with osteoporosis (abstr). Physiotherapy Canada 1990;42(suppl 3):14.
3. Lindsay R, Tohme JF: Estrogen treatment of patients with established postmenopausal osteoporosis. Obstes Gynecol 1990;76:290-5.
4. Christiansen C, Riis BJ: 17ß-estradiol and continuous norethistrone: A unique treatment for established osteoporosis in elderly women. J Clin Endocrinol Metab 1990;17:836-41.
5. Report from the 1993 Consensus Conference of the Osteoporosis Society of Canada. Ovarian hormone therapy for women: Effects on skeletal and extraskeletal tissues. Can Med Assoc J 1996;(in press).
6. Felson DT, Zhang Y, Hannan MT, et al: The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med 1993;329:1141-6.
7. Adachi JD, Bensen WG, Fawcett PD, et al: A randomized double-blind placebo controlled trial of medroxyprogesterone acetate in hysterectomized women on estrogen replacement therapy: Changes in bone density and lipids over one year (abstr). Arthritis Rheum 1994;(suppl)37:S2888.
8. Civitelli R, Gonnelli S, Zacchei F, et al: Bone turnover in postmenopausal osteoporosis: Effect of calcitonin treatment. J Clin Invest 1988;82:1268-74.
9. Overgaard K, Riis BJ, Christiansen C, et al: Effect of salcatonin given intranasally on early postmenopausal bone loss. BMJ 1989;299:477-9.
10. Harris ST, Watts NB, Jackson RD, et al: Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis. Am J Med 1993;95:557-67.
11. Storm T, Thamsborg G, Steiniche T, et al: Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med 1990;322:1265-71.
12. Liberman UA, Weiss SR, Broll J, et al: Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med 1995;333:1437-43.
13. Giannini S, D'Angelo A, Malvasi L, et al: Effects of one-year cyclical treatment with clodronate on postmenopausal bone loss. Bone 1993;14:137-41.
14. Reginster JY, Deriosy R, Denis D, et al: Prevention of postmenopausal bone loss by tiludronate. Lancet 1989;2:1469-71.